FindArticles - Search Alert -FindArticles - Search Alert - Be alerted whenever your search results change on FindArticles.com.Biotech Business - EXELIXIS INITIATES PHASE 1 CLINICAL TRIAL FOR XL999.- December 1, 2004 December 1, 2004 -- Exelixis, Inc. (NASDAQ:EXEL), South San Francisco, has initiated a Phase I clinical trial to evaluate the tolerability and pharmacokinetic profile of...http://findarticles.com/p/articles/mi_go2401/is_200412/ai_n7463101 Biotech Business - CLEARANT ASSURES MICROBIAL STERILTYALLOGRAFT PERFORMANCE.- December 1, 2004 December 1, 2004 -- It is well-established that conventionally processed human tissue implants carry an inherent risk of contamination, including infections at the...http://findarticles.com/p/articles/mi_go2401/is_200412/ai_n7463849 Biotech Business - SIGMA UNVEILS NEW PLASMID DNA ISOLATION METHOD.- December 1, 2004 December 1, 2004 -- Sigma, a division of Sigma-Aldrich Corporation (NASDAQ:SIAL), has introduced a new plasmid DNA isolation method designed to help researchers achieve...http://findarticles.com/p/articles/mi_go2401/is_200412/ai_n7459447 Biotech Business - METABOLISMPROTEIN PROCESSING LINKED TO SCHIZOPHRENIA.- December 1, 2004 December 1, 2004 -- Psychiatric Genomics, Inc., Gaithersburg, MD., has announced new findings concerning the potential cause of schizophrenia. The results showed that...http://findarticles.com/p/articles/mi_go2401/is_200412/ai_n7460792 |